Calendar
Prev MonthPrev Month Next MonthNext Month
MPS Advocacy Day
Wednesday, October 04, 2023, 9:30 AM - 11:30 AM EST
Category: Upcoming Events

Advocacy Day on Beacon Hill

Wednesday, October 4, 2023

If you are attending, please make certain that you have registered so that we have a head count for food. Please email [email protected] no later than Wednesday, September 27. (Additional Details below)

Also, please make certain you are reaching out to set up your appointments with your individual legislators any time after 11:30 a.m. once the speaking portion of the advocacy day is over. Please, prior to Advocacy Day, make appointments to visit your individual legislators or their staff person, House and Senate. If you do not know who your legislator is, please visit: https://www.sec.state.ma.us/WhereDoIVoteMA

To contact your legislator (email is best): 
https://malegislature.gov/Legislators/Members/Senate
https://malegislature.gov/Legislators/Members/House

Attached again for your review and to speak to your legislators are the pieces of legislation the MPs legislation on prior authorization on medication it's infographic and fact sheet if you have any questions before we see each other on October 4th please feel free to reach out. We are requesting that you speak to your legislators about our MPS legislation relative to prior authorization on medication.

https://malegislature.gov/Bills/193/S677
https://malegislature.gov/Bills/193/H941

Additionally, please discuss with legislators what you are seeing on the frontline of patient care!

HB 941/SB 677: An Act relative to utilization review

This bill:

  • Eliminates prior authorization for:
    • Generic medications that are not controlled substances
    • Generic and brand medications after six months of adherence (excludes controlled substances)
    • Dosage changes of the same medication
    • Therapeutic duplication if the treatment was previously approved
    • Long-acting injectable antipsychotics
    • Generic and brand name FDA-approved treatment for OUD
  • Requires that insurers and PBMs adhere to a 48-hour appeal process
  • Requires denials and denial reviews be conducted by physicians in the same or similar specialty